Dow Up0.35% Nasdaq Down0.02%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
3.98 Down 0.05(1.24%) Aug 20, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents48,490  81,512  30,075  
Short Term Investments42,986  19,087  9,650  
Net Receivables -   -   -  
Inventory -   -   -  
Other Current Assets765  786  561  
Total Current Assets 92,241   101,385   40,286  
Long Term Investments -   -   -  
Property Plant and Equipment1,553  1,174  1,407  
Goodwill -   -   -  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets1,409  458  631  
Deferred Long Term Asset Charges -   -   -  
Total Assets 95,203   103,017   42,324  
Liabilities
Current Liabilities
Accounts Payable22,714  15,549  10,902  
Short/Current Long Term Debt9,493  7,937  4,246  
Other Current Liabilities -   -   -  
Total Current Liabilities 32,207   23,486   15,148  
Long Term Debt13,905  4,465  12,402  
Other Liabilities -   -   -  
Deferred Long Term Liability Charges -   -   -  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 46,112   27,951   27,550  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock9  7  5  
Retained Earnings(551,412)(461,220)(398,430)
Treasury Stock -   -   -  
Capital Surplus600,477  536,277  413,196  
Other Stockholder Equity17  2  3  
Total Stockholder Equity 49,091   75,066   14,774  
Net Tangible Assets 49,091   75,066   14,774  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.